首页> 外文期刊>Anticancer Research: International Journal of Cancer Research and Treatment >Mutation analysis of IgVH genes in splenic marginal zone lymphomas: correlation with clinical characteristics and outcome.
【24h】

Mutation analysis of IgVH genes in splenic marginal zone lymphomas: correlation with clinical characteristics and outcome.

机译:脾边缘区淋巴瘤IgVH基因突变分析:与临床特征和预后的关系。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: To determine the immunoglobulin variable heavy chain (IgVH) gene usage and somatic mutation patterns in a series of SMZL patients and to correlate these findings with the clinical features and outcome. PATIENTS AND METHODS: IgVH genes were amplified and sequenced from 22 SMZL cases. Clinical and laboratory data of these patients were recorded. RESULTS: A biased usage of IgVH gene was found with overrepresentation of VH3 in 16/22 cases. A total of 13/22 (59%) of cases were found to have mutated IgVH genes, whereas 9/22 (41%) were unmutated. Positive antigen selection process was identified in two cases. Treatment was different between the cases with mutation and those without. No differences in clinical and laboratory characteristics, or survival were found between the mutated and unmutated cases. CONCLUSION: SMZL are characterized by marked molecular heterogeneity. A biased usage of certain sequences suggests antigen selection. Prognostic significance of mutational status was not confirmed in this study. However further studies are needed in order to confirm these results.
机译:背景:确定一系列SMZL患者的免疫球蛋白可变重链(IgVH)基因使用情况和体细胞突变模式,并将这些发现与临床特征和结果相关联。病人和方法:从22例SMZL病例中扩增和测序了IgVH基因。记录这些患者的临床和实验室数据。结果:在16/22例患者中发现IgVH基因使用偏倚,VH3过高。共有13/22(59%)的病例发现了IgVH基因突变,而9/22(41%)的病例没有突变。在两例病例中鉴定出阳性抗原选择过程。有突变的病例与没有突变的病例的治疗方法不同。在突变和未突变的病例之间,在临床和实验室特征或存活率方面均未发现差异。结论:SMZL具有明显的分子异质性。某些序列的偏向用法提示抗原选择。这项研究没有证实突变状态的预后意义。但是,需要进一步的研究以证实这些结果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号